Document Detail


Clinical pharmacology as a cornerstone of orphan drug development.
MedLine Citation:
PMID:  22037026     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
A recent US Food and Drug Administration (FDA) advisory committee meeting highlighted the potential of clinical pharmacology to overcome challenges in orphan drug development.
Authors:
Edward D Bashaw; Shiew-Mei Huang; Timothy R Coté; Anne R Pariser; Christine E Garnett; Gilbert Burckart; Lei Zhang; Angela Y Men; Christine D Le; Rosane Charlab; Jogaro V Gobburu; Lawrence J Lesko
Related Documents :
22048536 - A clinical trial of pippali (piper longum linn.) with special reference to abheshaja.
21953396 - Overview of anti-infective drug development.
22037026 - Clinical pharmacology as a cornerstone of orphan drug development.
22039796 - Use of macrocyclic lactones in cattle in the usa.
1883776 - Long duration local anesthesia with lecithin-coated microdroplets of methoxyflurane: st...
1298086 - Artemether in the treatment of multiple drug resistant falciparum malaria.
Publication Detail:
Type:  Journal Article     Date:  2011-10-31
Journal Detail:
Title:  Nature reviews. Drug discovery     Volume:  10     ISSN:  1474-1784     ISO Abbreviation:  Nat Rev Drug Discov     Publication Date:  2011  
Date Detail:
Created Date:  2011-10-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101124171     Medline TA:  Nat Rev Drug Discov     Country:  England    
Other Details:
Languages:  eng     Pagination:  795-6     Citation Subset:  IM    
Affiliation:
Office of Translational Sciences, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland 20993, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  PPAR? is down-regulated following liver transplantation in mice.
Next Document:  Vemurafenib.